Discusses SCOPE Phase II Data: iSCIB1+ Shows Improved Progression-Free Survival in Advanced Melanoma December 11, 2025 9:00 ...
These AI startups founded by bright young minds in their teens and early 20s are disrupting industries and attracting top ...